Bibliographie - 4768 - Stabilis 4.0

Viimane versioon :
08/05/2024

Viited 4768

Tüüp :

Ajaleht

Uurimisrühmad :

Tokyo - Nippon Medical School Hospital, Department of Pharmacy

Autor :

Kondo M, Genpei M, Watanabe K, Yoshida M, Tagui N, Fukao S, Sugaya K, Takase H.

Pealkiri :

Y-site injection physical compatibility of remdesivr with select intravenous drugs used in palliative care and for treating coronavirus disease 2019.

Publikatsioon :

Journal of Nippon Medical school 2023

Tõendite tase :

Füüsikaline stabiilsus :

Keemiline püsivus :

Muud meetodid :

Kommentaarid :

Ingredientide nimekiri

Fentanyl citrate

50 µg/ml

Remdesivir

1 mg/ml

Furosemide

10 mg/ml

Remdesivir

1 mg/ml

Heparin sodium

1000 UI/ml

Remdesivir

1 mg/ml

Hydromorphone hydrochloride

1 mg/ml

Remdesivir

1 mg/ml

Morphine hydrochloride

10 mg/ml

Remdesivir

1 mg/ml

Octreotide acetate

0,030 mg/ml

Remdesivir

1 mg/ml

Oxycodone hydrochloride

10 mg/ml

Remdesivir

1 mg/ml

Remdesivir

1 mg/ml			+
1 mg/ml			+
1 mg/ml	+ Fentanyl citrate	50 µg/ml	+
1 mg/ml	+ Furosemide	10 mg/ml	+
1 mg/ml	+ Heparin sodium	1000 UI/ml	+
1 mg/ml	+ Hydromorphone hydrochloride	1 mg/ml	+
1 mg/ml	+ Morphine hydrochloride	10 mg/ml	+
1 mg/ml	+ Octreotide acetate	0,030 mg/ml	+
1 mg/ml	+ Oxycodone hydrochloride	10 mg/ml	+

Mentions Légales